A Quote by Scott Gottlieb

The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after substantial price hikes that these drugs offer enough revenue to offset the rising generic entry costs, and start to entice competition.
One of the biggest factors fueling the angst over drug prices in the U.S. is that some older medicines that should be sold cheaply as generics are still priced very high, often owing to a dwindling number of generic competitors and the rising cost of producing these drugs.
Increasing patient access to more affordable, FDA-approved generic and biosimilar medicines is a proven and tested solution to lowering prescription drug costs.
The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors.
The regulatory approach of the Food and Drug Administration and the Patent and Trademark Office has driven up the costs of generic drugs.
EpiPen is not unique. It falls into a category of old drugs, many of which should have long been subject to generic competition.
One dirty tactic big pharmaceutical companies use is keeping drug prices artificially high through anti-competitive conduct, such as paying competitors millions of dollars to stop them from creating generic drugs.
The same drugs are way cheaper in Germany than in America because, obviously, if all sickness funds negotiate with the drug companies for a single price, then the market power of the sickness funds is fully used. So therefore you would expect the prices to be lower for the drugs in Germany, and this is exactly what you see, at least for non-generic drugs.
'Chels-emojis' are in the works. I use emojis heavily in life, and I think a lot of people do. There are a number that are frustratingly absent - you know how there's kind of a generic white man and a generic white woman? I just want to put a generic black man and a generic black woman.
Everyone is talking about sustainability and resilience, yet all that knowledge is thrown in the bin. [Lagos is] a unique case, but also a test case. It's unbelievably unique, but also it's now considered with a number of really generic opinions, generic solution, generic expectations.
With the Health Impact Fund, the innovation is paid for separately, through publicly funded health impact rewards, and the product is sold at the cost of production to all. Here, the cruel injustice of preventing the poor from buying at cost - evidenced by today's suppression of the trade in generic versions of patented medicines - would no longer be needed.
The Law of the Generic: One of the fastest routes to failure is giving a brand a generic name.
I'm just trying to avoid any sort of generic kind of music - I don't want to do generic jazz or fusion.
Biologics must be grown in living systems - fermented, for example, in large vats of bacteria cells. This makes them hard to replicate. For decades, biologics weren't subject to competition from copycat generic medicines, even once patents and exclusivities had lapsed on originals.
Our approach is to reject the old vicious circle of the '80s-rising debt, higher long-term interest rates, higher debt repayment costs, lower growth, higher unemployment, then enforced cuts in public spending. That was the old boom and bust.
The generic Canadian style of illustration is different from the generic American style.
Cipla has already developed a generic version, oseltamivir, which would be much cheaper than Tamiflu, the only available drug effective in treating avian flu.
This site uses cookies to ensure you get the best experience. More info...
Got it!